ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 927,02
0,06%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) Actualités

NMTC NeuroOne Medical Technologies Corporation

1,1899
-0,0201 (-1,66%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NeuroOne Medical Technologies Corporation NMTC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0201 -1,66% 1,1899 01:19:56
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,23 1,15 1,231 1,17 1,21
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/4/202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09/4/202415:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
04/4/202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
26/3/202414:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
08/3/202418:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
04/3/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
21/2/202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:15EDGAR2Form 8-K - Current report
13/2/202422:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
08/2/202421:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
01/2/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202415:02EDGAR2Form ARS - Annual Report to Security Holders
29/1/202415:00EDGAR2Form DEF 14A - Other definitive proxy statements
05/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:35EDGAR2Form 144 - Report of proposed sale of securities
15/12/202322:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/12/202322:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/12/202322:30EDGAR2Form 8-K - Current report
14/12/202322:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
11/12/202314:15EDGAR2Form 8-K - Current report
11/12/202314:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
07/12/202322:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
04/12/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202314:00EDGAR2Form 8-K - Current report
16/11/202314:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
14/11/202323:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
14/11/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202314:15EDGAR2Form 8-K - Current report
07/11/202314:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

Dernières Valeurs Consultées

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés